Description
Book SynopsisTable of ContentsDisparities in Breast Cancer Outcomes and How to Resolve Them Testing for Inherited Susceptibility to Breast Cancer Breast Cancer Pathology in the Era of Genomics Breast Cancer Pathology in the Era of Genomics Role of Ovarian Suppression in Early Premenopausal Breast Cancer Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer Biology and Treatment of HER2-Low Breast Cancer Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Multidisciplinary Management of Brain Metastasis from Breast Cancer Systemic Therapy for Hereditary Breast Cancers Evidence-Based Guidance for Breast Cancer Survivorship
